Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery?

被引：0
|
作者：
Carolyn Runowicz
机构：
[1] Director of the Neag Comprehensive Cancer Center at the University of Connecticut Health Center,
来源：
Nature Clinical Practice Oncology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：416 / 417
页数：1
相关论文
共 50 条
  • [31] Consolidation hyperthermic intraperitoneal chemotherapy and maintenance chemotherapy following laparoscopic cytoreductive surgery in the treatment of ovarian carcinoma
    Rettenmaier, Mark A.
    Mendivil, Alberto A.
    Abaid, Lisa N.
    Brown, John V., III
    Wilcox, Amber M.
    Goldstein, Bram H.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2015, 31 (01) : 8 - 14
  • [32] Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer
    Bai, Yun
    Du, Ye
    Ye, Pengpeng
    Luo, Yang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
    Ansaloni, Luca
    Agnoletti, Vanni
    Amadori, Andrea
    Catena, Fausto
    Cavaliere, Davide
    Coccolini, Federico
    De Iaco, Pierandrea
    Di Battista, Monica
    Framarini, Massimo
    Gazzotti, Filippo
    Ghermandi, Claudio
    Kopf, Barbara
    Saponara, Maristella
    Tauceri, Francesca
    Vallicelli, Carlo
    Verdecchia, Giorgio Maria
    Pinna, Antonio Daniele
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 778 - 785
  • [34] CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY IMPROVES SURVIVAL IN PATIENTS WITH STAGE IIIC OVARIAN CANCER
    Li, Zhen
    Cai, Hongbing
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 233 - 233
  • [35] Model for prediction of delayed chemotherapy following cytoreductive surgery in patients with epithelial ovarian cancer
    Newlin, E. M.
    Connor, E. V.
    Han, X.
    Mahdi, H.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 192 - 193
  • [36] Reply to: Initial experience with hyperthermic intraperitoneal chemotherapy and cytoreductive surgery
    Macri, A.
    Fleres, F.
    Cucinotta, E.
    Saladino, E.
    INDIAN JOURNAL OF CANCER, 2014, 51 (04) : 437 - 437
  • [37] Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Iugai, Sergei
    Sardi, Armando
    Diaz-Montes, Teresa
    King, Mary Caitlin
    Kovalik, Vladislav
    Falla-Zuniga, Luis Felipe
    Uzhegova, Kseniia
    Ledakis, Panayotis
    Nieroda, Carol
    Gushchin, Vadim
    GYNECOLOGIC ONCOLOGY REPORTS, 2025, 58
  • [38] Morbidity and Mortality following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Diabetes
    Randle, R. W.
    Swett, K. R.
    Stewart, J. H.
    Shen, P.
    Levine, E. A.
    Votanopoulos, K. I.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S87 - S87
  • [39] Robotic and Open Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in the Management of Recurrent Ovarian Cancer
    Kreafle, Johanna E.
    Diaz, John P.
    Angel, Kristina
    Estape, Richard
    Schroeder, Eric
    Estape, Ricardo
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 184S - 184S
  • [40] Survival of patients with advanced ovarian cancer treated with intermittent chemotherapy following cytoreductive surgery and adjuvant chemotherapy
    Amikura T.
    Aoki Y.
    Kase H.
    Watanabe M.
    Sato T.
    Fujita K.
    Kurata H.
    Tanaka K.
    International Journal of Clinical Oncology, 2002, 7 (1) : 45 - 50
12345